198 related articles for article (PubMed ID: 24047276)
1. Sarcoidosis lymphoma syndrome - the value of PET-CT in the diagnosis.
Kis A; Eszes N; Tamasi L; Losonczy G; Csekeo A; Csomor J; Muller V
World J Surg Oncol; 2013 Sep; 11():235. PubMed ID: 24047276
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of sarcoidosis-lymphoma syndrome lesions: a case report on the use of two different positron emission tomography tracers.
Yudistiro R; Arisaka Y; Tokue A; Nakajima T
BMC Med Imaging; 2016 Jan; 16():1. PubMed ID: 26746426
[TBL] [Abstract][Full Text] [Related]
3. Sarcoidosis misdiagnosed as malignant tumors: a case report.
Li Z; Li X; Song Z; Liu J; Dong M; Shi T; Ren D; Xu S; Chen J
World J Surg Oncol; 2015 Dec; 13():333. PubMed ID: 26652015
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans.
Eloubeidi MA; Cerfolio RJ; Chen VK; Desmond R; Syed S; Ojha B
Ann Thorac Surg; 2005 Jan; 79(1):263-8. PubMed ID: 15620955
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary BALT lymphoma successfully treated with eight cycles weekly rituximab: report of first case and F-18 FDG PET/CT images.
Bilici A; Seker M; Ustaalioglu BB; Canpolat N; Salepci T; Gumus M
J Korean Med Sci; 2011 Apr; 26(4):574-6. PubMed ID: 21468267
[TBL] [Abstract][Full Text] [Related]
6. Use of integrated FDG-PET/CT in sarcoidosis.
Krüger S; Buck AK; Mottaghy FM; Pauls S; Schelzig H; Hombach V; Reske SN
Clin Imaging; 2008; 32(4):269-73. PubMed ID: 18603181
[TBL] [Abstract][Full Text] [Related]
7. (18)F-FDG and (18)F-FLT PET/CT imaging in the characterization of mediastinal lymph nodes.
Rayamajhi SJ; Mittal BR; Maturu VN; Agarwal R; Bal A; Dey P; Shukla J; Gupta D
Ann Nucl Med; 2016 Apr; 30(3):207-16. PubMed ID: 26661845
[TBL] [Abstract][Full Text] [Related]
8. [Value of 18F-fluorodeoxyglucose-PET in the diagonosis and monitoring of pulmonary sarcoidosis: a case report].
Kaneko M; Tomioka H; Kaneda T; Kubot M; Tani S; Fujii H; Katsuyama E; Okazaki M
Nihon Kokyuki Gakkai Zasshi; 2008 Jun; 46(6):505-9. PubMed ID: 18593000
[TBL] [Abstract][Full Text] [Related]
9. Sarcoidosis development during induction chemotherapy for lung cancer mimicked progressive disease.
Umezu H; Chida M; Inoue T; Araki O; Tamura M; Tatewaki M; Fukushima Y; Honma K
Gen Thorac Cardiovasc Surg; 2010 Aug; 58(8):434-7. PubMed ID: 20703868
[TBL] [Abstract][Full Text] [Related]
10. [Sarcoidosis-lymphoma syndrome showing abnormal FDG uptake in lymph nodes and muscles upon post-chemotherapy PET/CT imaging].
Nakano K; Ito Y; Takagi F; Uchiyama S; Yoda A; Sakamoto N; Takaba M; Adachi M; Takemura T; Nagata Y; Ono T
Rinsho Ketsueki; 2019; 60(4):302-307. PubMed ID: 31068560
[TBL] [Abstract][Full Text] [Related]
11. 18F-FDG PET/CT for early response assessment in diffuse large B-cell lymphoma: poor predictive value of international harmonization project interpretation.
Cashen AF; Dehdashti F; Luo J; Homb A; Siegel BA; Bartlett NL
J Nucl Med; 2011 Mar; 52(3):386-92. PubMed ID: 21321279
[TBL] [Abstract][Full Text] [Related]
12. High SUV uptake on FDG-PET/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG-PET/CT staging in lymphoma.
Ngeow JYY; Quek RHH; Ng DCE; Hee SW; Tao M; Lim LC; Tan YH; Lim ST
Ann Oncol; 2009 Sep; 20(9):1543-1547. PubMed ID: 19474116
[TBL] [Abstract][Full Text] [Related]
13. Sarcoid-like reaction mimics progression of disease after induction chemotherapy for lung cancer.
Chida M; Inoue T; Honma K; Murakami K
Ann Thorac Surg; 2010 Dec; 90(6):2031-3. PubMed ID: 21095358
[TBL] [Abstract][Full Text] [Related]
14. [Contingent diagnosis of sarcoidosis by 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) after completion of chemotherapy for malignant lymphoma].
Iino M; Iizuka C
Rinsho Ketsueki; 2012 May; 53(5):540-2. PubMed ID: 22728558
[TBL] [Abstract][Full Text] [Related]
15. Utilization of 18F-FDG PET/CT as a staging tool in patients with newly diagnosed lymphoma.
Cho SF; Chang CC; Liu YC; Chang CS; Hsiao HH; Liu TC; Huang CT; Lin SF
Kaohsiung J Med Sci; 2015 Mar; 31(3):130-7. PubMed ID: 25744235
[TBL] [Abstract][Full Text] [Related]
16. [Usefulness of fluorodeoxyglucose-positron emission tomography in a case of pleural sarcoidosis].
Hattori T; Konno S; Inomata T; Nasuhara Y; Betsuyaku T; Nishimura M
Nihon Kokyuki Gakkai Zasshi; 2009 Jul; 47(7):658-62. PubMed ID: 19637812
[TBL] [Abstract][Full Text] [Related]
17. F-18 fluorodeoxyglucose and F-18 fluorothymidine positron emission tomography/computed tomography imaging in a case of neurosarcoidosis.
Kim SK; Im HJ; Kim W; Kim TS; Hwangbo B; Kim HJ
Clin Nucl Med; 2010 Feb; 35(2):67-70. PubMed ID: 20090446
[TBL] [Abstract][Full Text] [Related]
18.
Chauvelot P; Skanjeti A; Jamilloux Y; de Parisot A; Broussolle C; Denis P; Ramackers JM; Giammarile F; Kodjikian L; Seve P
Br J Ophthalmol; 2019 Nov; 103(11):1650-1655. PubMed ID: 30658987
[TBL] [Abstract][Full Text] [Related]
19. Cervical lymph node hyperplasia on [(18)F]-fluorodeoxyglucose positron emission tomography/computed tomography scan after treatment of children and adolescents with malignant lymphoma.
Hu YY; Zhang X; Long W; Lin XP; Zhang YR; Li YH; Xiao ZZ; Zheng RL; Liang PY; Fan W
Eur J Radiol; 2015 Jul; 84(7):1378-82. PubMed ID: 25882963
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDG PET scanning in pulmonary amyloidosis.
Baqir M; Lowe V; Yi ES; Ryu JH
J Nucl Med; 2014 Apr; 55(4):565-8. PubMed ID: 24556593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
